EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Klinische Studie (Phase I)

Phase 1/2 study of a WT1 peptide-dosing emulsion in pediatric patients with recurrent/refractory diffuse intrinsic pontine glioma, glioblastoma, or anaplastic astrocytoma

Yoshiko Hashii, Hiroyuki Fujisaki, Keita Terashima, Hiroaki Goto, Keizo Horibe, Kazuhiko Sugiyama, Mariko Takahara-Matsubara, Masashi Goto, Takaaki Yanagisawa, Atsushi Kikuta, Hiroshi Kawamoto, Naoya Hashimoto und 3 weitere

European Journal of Cancer · 2026-06 · 242 · 116808

DOI: 10.1016/j.ejca.2026.116808 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift European Journal of Cancer, 2026-06. Verfasst von Yoshiko Hashii und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, the University of Osaka Graduate School of Medicine, Suita, Japan. Electronic address: yoshiko.hashii@oici.jp. Hauptthemen laut MEDLINE: WT1 Proteins, Brain Stem Neoplasms, Diffuse Intrinsic Pontine Glioma, Cancer Vaccines. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Sumitomo Pharma Co Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The prognosis of pediatric patients with diffuse intrinsic pontine glioma (DIPG), glioblastoma, or anaplastic astrocytomas (AAs) is dismal. This first-in-child phase 1/2 study examined the safety and efficacy of a Wilms' tumor gene 1 (WT1) peptide vaccine, along with the associations of delayed-type hypersensitivity (DTH) and cytotoxic T lymphocyte (CTL) frequency/count with clinical outcomes. METHODS: Patients (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WT1 ProteinsBrain Stem NeoplasmsDiffuse Intrinsic Pontine GliomaCancer VaccinesAstrocytomaGlioblastomaNeoplasm Recurrence, LocalHumansFemaleMaleChildChild, PreschoolAdolescentProtein Subunit Vaccines

Stichwörter der Autor:innen

Brain tumorCancer immunotherapyDiffuse intrinsic pontine gliomaPediatricPeptide vaccinePhase ½Wilms’ tumor gene 1

Substanzen

WT1 ProteinsCancer VaccinesWT1 protein, humanProtein Subunit Vaccines

Autor:innen und Institutionen

  • Department of Pediatrics, the University of Osaka Graduate School of Medicine, Suita, Japan. Electronic address: yoshiko.hashii@oici.jp.
  • Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan.
  • Division of Neuro-Oncology, Children's Cancer Center, National Center for Child Health and Development, Setagaya-ku, Japan.
  • Division of Hematology/Oncology, Kanagawa Children's Medical Center Childhood Cancer Center, Yokohama, Japan.
  • Clinical Research Center, NHO Nagoya Medical Center, Nagoya, Japan.
  • Department of Clinical Oncology & Neuro-oncology Program, Hiroshima University Hospital, Hiroshima, Japan.

Förderung

  • Sumitomo Pharma Co Ltd

Zitieren

APA

Hashii, Y., Fujisaki, H., Terashima, K., Goto, H., Horibe, K., Sugiyama, K., Takahara-Matsubara, M., Goto, M., Yanagisawa, T., Kikuta, A., Kawamoto, H., Hashimoto, N., Oka, Y., Sugiyama, H., & Hara, J. (2026). Phase 1/2 study of a WT1 peptide-dosing emulsion in pediatric patients with recurrent/refractory diffuse intrinsic pontine glioma, glioblastoma, or anaplastic astrocytoma. European Journal of Cancer, 242, 116808. https://doi.org/10.1016/j.ejca.2026.116808

Vancouver

Hashii Y, Fujisaki H, Terashima K, Goto H, Horibe K, Sugiyama K, et al. Phase 1/2 study of a WT1 peptide-dosing emulsion in pediatric patients with recurrent/refractory diffuse intrinsic pontine glioma, glioblastoma, or anaplastic astrocytoma. European Journal of Cancer. 2026;242:116808. doi:10.1016/j.ejca.2026.116808

BibTeX
@article{Hashii2026,
  author = {Hashii, Yoshiko and Fujisaki, Hiroyuki and Terashima, Keita and Goto, Hiroaki and Horibe, Keizo and Sugiyama, Kazuhiko and Takahara-Matsubara, Mariko and Goto, Masashi and Yanagisawa, Takaaki and Kikuta, Atsushi and Kawamoto, Hiroshi and Hashimoto, Naoya and Oka, Yoshihiro and Sugiyama, Haruo and Hara, Junichi},
  title = {Phase 1/2 study of a WT1 peptide-dosing emulsion in pediatric patients with recurrent/refractory diffuse intrinsic pontine glioma, glioblastoma, or anaplastic astrocytoma},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {242},
  pages = {116808},
  doi = {10.1016/j.ejca.2026.116808}
}
Kostenlos starten →